JPMORGAN CHASE & CO – Vertex Pharmaceuticals Incorporated Transaction History
JPMORGAN CHASE & CO portfolio value:
$1.40B
portfolio value
JPMORGAN CHASE & CO quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.21% | -377.85K shares | -68.81M | $289.54 | 4.85M |
| Q2 2022 | share | Increase | +8.83% | 424.87K shares | 219.92M | $281.79 | 5.23M |
| Q1 2022 | share | Increase | +7.80% | 348.33K shares | 275.59M | $260.97 | 4.81M |
| Q4 2021 | share | Increase | +6.00% | 252.59K shares | 216.40M | $222.45 | 4.46M |
| Q3 2021 | share | Decrease | -5.10% | -226.33K shares | -130.87M | $181.39 | 4.21M |
| Q2 2021 | share | Increase | +38.42% | 1.23M shares | 205.84M | $201.63 | 4.43M |
| Q1 2021 | share | Increase | +23.89% | 618.27K shares | 77.34M | $214.89 | 3.20M |
| Q4 2020 | share | Increase | +15.55% | 348.21K shares | 6.21M | $236.34 | 2.58M |
| Q3 2020 | share | Increase | +6.00% | 126.72K shares | -8.00M | $272.12 | 2.23M |
| Q2 2020 | share | Decrease | -3.72% | -81.68K shares | 91.20M | $290.31 | 2.11M |
| Q1 2020 | share | Decrease | -15.11% | -390.61K shares | -43.82M | $237.95 | 2.19M |
| Q4 2019 | share | Decrease | -23.37% | -788.42K shares | -5.51M | $218.95 | 2.58M |
| Q3 2019 | share | Decrease | -22.15% | -959.88K shares | -202.32M | $169.42 | 3.37M |
| Q2 2019 | share | Decrease | -36.12% | -2.44M shares | -473.93M | $183.38 | 4.33M |
| Q1 2019 | share | Decrease | -5.62% | -403.88K shares | 56.80M | $183.95 | 6.78M |
| Q4 2018 | share | Increase | +0.99% | 70.30K shares | -180.72M | $165.71 | 7.18M |
| Q3 2018 | share | Increase | +5.25% | 355.13K shares | 222.48M | $192.74 | 7.11M |
| Q2 2018 | share | Decrease | -15.31% | -1.22M shares | -152.02M | $169.96 | 6.76M |
| Q1 2018 | share | Decrease | -15.04% | -1.41M shares | -107.06M | $162.98 | 7.98M |
| Q4 2017 | share | Increase | +0.81% | 75.50K shares | 13.54M | $149.86 | 9.39M |
| Q3 2017 | share | Increase | +11.21% | 939.89K shares | 314.56M | $152.04 | 9.32M |
| Q2 2017 | share | Decrease | -10.46% | -978.82K shares | 56.59M | $128.87 | 8.38M |
| Q1 2017 | share | Decrease | -11.66% | -1.23M shares | 242.74M | $109.35 | 9.36M |
| Q4 2016 | share | Decrease | -3.90% | -430.14K shares | -181.18M | $73.67 | 10.59M |
| Q3 2016 | share | Decrease | -9.42% | -1.14M shares | -85.04M | $87.21 | 11.02M |
| Q2 2016 | share | Increase | +4.15% | 485.11K shares | 118.05M | $86.02 | 12.17M |
| Q1 2016 | share | Decrease | -7.37% | -929.73K shares | -658.62M | $79.49 | 11.68M |